Author: Dr. David Lowemann

FDA Approves Ketamine-based Nose Spray for Depression

The U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray Spravato to treat adults with major depressive disorder (MDD), the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on January 21, 2025

Most Dementia Patients Unaware of Diagnosis

Many elderly people and their caregivers don’t know a doctor has diagnosed them with dementia. More than three-quarters of patients with dementia were not aware of their diagnosis, according to results recently published in the Journal of General Internal Medicine. It’s not… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on January 21, 2025

Dogs Paired With Providers at Hospitals Help Ease Staff and Patient Stress

DENVER — Outside HCA HealthONE Rose medical center, the snow is flying. Inside, on the third floor, there’s a flurry of activity within the labor and delivery unit. “There’s a lot of action up here. It can be very stressful at times,” said Kristina Fraser, an OB-GYN in blue scrubs. Nurses wheel a very pregnant […]

Published on January 21, 2025